Resiliency Program for Medical Interpreters

Psychological Stress Clinical Trial

— CARE  

Official title:

Developing a Resiliency Program for Medical Interpreters in Cancer Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02378597
• Other study ID #: 12-524
• Status: Completed
• Phase: Phase 1/Phase 2
• First received: June 27, 2014
• Last updated: March 3, 2015
• Start date: January 2014
• Est. completion date: June 2014

Study information

• Verified date: February 2015
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

To develop and test a 4-session program to teach resiliency skills to Medical Interpreters.

Description:

This study aims to improve quality of cancer care for LEP patients through improving medical interpreters' ability to cope with difficult encounters. We propose to (1) identify the needs of medical interpreters working with cancer patients, and (2) develop and test a psychoeducational resiliency program at 3 DF/HCC cancer centers: MGH, DFCI, and BWH) intended to enhance interpreters' skills to effectively manage stressful encounters and to cope with the personal effects of encounters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: June 2014
• Est. primary completion date: March 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Interpreter employed at one of the 3 study hospitals

2. >=20 hours/week

Exclusion Criteria:

1) Interpreter working <20 hours per week

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Psychological Stress
• Stress, Psychological

Intervention

Behavioral:
• Behavioral: Resiliency Intervention
4 hour behavioral session including education in the relaxation response, education about stress and allostatic load, cognitive skills building, review of difficult encounters with patients.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Massachusetts General Hospital	University of Massachusetts, Boston

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility and Acceptability of Intervention (participant feedback questionnaire)	A participant feedback questionnaire will be completed by participants, including questions about whether the logistics and content of the intervention were feasible and acceptable to them. Attendance to the sessions is also considered as a component of feasibility.	Post-Intervention (4 weeks)	No
Secondary	Psychological Variables including Perceived Stress and Resiliency ( PSS-1021 is a 10-item scale)	The PSS-1021 is a 10-item scale designed to measure the degree to which situations in one's life are appraised, or considered as stressful, and how unpredictable, uncontrollable, and overloaded respondents find their lives. Responses are on 4-item Likert scales and range from 10-40; higher score = greater stress.The Resiliency Scale is a 14-item self-report measure to assess one's ability to successfully deal with adversity.	Baseline, Post-Intervention (4 weeks), and 12 week follow up	No